Exhibit 99.1

 

 

 

Akerna Announces Financial Results for the Second Quarter 2021

 

Software revenue up 56%, total revenue up 63% year-over-year

 

DENVER, August 9, 2021 -- Akerna (Nasdaq: KERN), an enterprise software, leading compliance technology provider and developer of the cannabis industry’s first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform®), today reported its unaudited financial results for the quarter ended June 30, 2021.

 

“Our second quarter results continued the momentum in 2021, with revenue growth of 63% year over year driven by a mix of organic and inorganic software revenue and a rebound in consulting demand,” said Jessica Billingsley, CEO of Akerna. “As consolidation within the industry continues and emerging markets begin to open, we believe our industry leadership position with multi-state, international and emerging enterprises paves the way for Akerna to be one of the largest cannabis technology winners in the years ahead.”

 

Akerna is the technology ecosystem for cannabis. Through its family of software, which includes MJ Platform, Viridian Sciences, Ample Organics, Trellis, Leaf Data Systems, Last Call Analytics, and solo sciences, Akerna provides the only scalable cannabis ERP solution offering compliance, data, taxation, payments, seed-to-sale, track-and-trace, and consulting to operators, governments, and brands. In doing so, Akerna creates one of the world’s most transparent and accountable consumer packaged goods supply chains on a global scale.

 

Cannabis companies looking to scale alongside the rapidly expanding industry must leverage the right tools, and enterprise class software is essential to do so.

 

Second Quarter 2021 Financial Highlights

 

Software revenue was $4.5 million, up 56% year over year
Total revenue was $4.9 million, up 63% year over year
Gross profit was $3.0 million, up 153% year over year
Net loss was $6.1 million, flat with the same period last year
Adjusted EBITDA was negative $1.6 million compared to negative Adjusted EBITDA of $3.6 million for the same quarter prior year, an improvement of 54% year over year
Cash was $11.8 million as of June 30, 2021, compared to $15.4 million as of March 31, 2021

 

See “Explanation of Non-GAAP Financial Measures” below

 

Second Quarter 2021 Key Metrics

 

Total SaaS ARR of $17.3 million, up 53% year over year
Average new B2B order up 27% year over year
B2B transaction volume up 104% year over year
New Bookings ARR of approximately $900,000

 

 

 

 

Second Quarter 2021 Operational Highlights

 

Secures world’s first national government cannabis contract with St. Vincent and the Grenadines
Closed Viridian Acquisition
Added Pharmaceutical and Cannabis Industry Expert Barry Fishman to Board of Directors
Completed MJ Retail (POS offering) beta adoption

 

The foregoing financial results are preliminary in nature. Final financial results and other disclosures will be reported in Akerna’s quarterly report on Form 10-Q and may differ materially from the results and disclosures today due to, among other things, the completion of final review procedures, the occurrence of subsequent events or the discovery of additional information. You are encouraged to review the Form 10-Q in detail.

 

Conference Call Details

 

Akerna will host a conference call tomorrow, Tuesday, August 10, 2021, at 8:30 a.m. Eastern Time to discuss its financial results and business highlights. A question-and-answer session will follow prepared remarks.

Interested parties may listen to the call by dialing:

 

Toll-Free: 1-877-407-3982

Toll / International: +1-201-493-6780

Conference ID: 13721125

 

The conference call will also be available via a live, listen-only webcast and can be accessed through the Investor Relations section of Akerna’s website, https://ir.akerna.com/

 

To be included on the Company’s email distribution list, please sign up at https://ir.akerna.com/news-events/email-alerts

 

About Akerna

Akerna (Nasdaq: KERN) is an enterprise software company focused on compliantly serving the cannabis, hemp, and CBD industry. First launched in 2010, Akerna has tracked more than $20 billion in cannabis sales to date and is the first cannabis software company listed on Nasdaq. The company’s cornerstone technology, MJ Platform, the world’s leading infrastructure as a service platform, powers retailers, manufacturers, brands, distributors, and cultivators.

 

For more information, visit https://www.akerna.com/.

 

Investor Contacts

Sapphire Investor Relations, LLC

Erica Mannion or Michael Funari

(617) 542-6180

IR@akerna.com

 

2

 

 

Forward Looking Statements

 

Certain statements made in this release are “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. Such forward-looking statements include but are not limited to statements regarding our preliminary financial results which may differ from our final financial results, our belief that our industry leadership position with multi-state, international and emerging enterprises will enable us to be one of the largest cannabis technology winners in the years ahead and the timing for management’s conference call in relation to our quarterly results. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of significant known and unknown risks, uncertainties, assumptions, and other important factors, many of which are outside Akerna’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others that may affect actual results or outcomes, include (i) Akerna’s ability to maintain relationships with customers and suppliers and retain its management and key employees, (ii) changes in applicable laws or regulations, (iii) changes in the market place due to the coronavirus pandemic or other market factors, (iv) and other risks and uncertainties disclosed from time to time in Akerna’s filings with the U.S. Securities and Exchange Commission, including those under “Risk Factors” therein. You are cautioned not to place undue reliance on forward-looking statements. All information herein speaks only as of the date hereof, in the case of information about Akerna, or the date of such information, in the case of information from persons other than Akerna. Akerna undertakes no duty to update or revise the information contained herein. Forecasts and estimates regarding Akerna’s industry and end markets are based on sources believed to be reliable; however, there can be no assurance these forecasts and estimates will prove accurate in whole or in part.

 

Explanation of Non-GAAP Financial Measures:

 

In addition to our results determined in accordance with U.S. generally accepted accounting principles (“GAAP”), we believe the following non-GAAP measures are useful in evaluating our operating performance. We use the following non-GAAP financial information to evaluate our ongoing operations and for internal planning and forecasting purposes. We believe that non-GAAP financial information, when taken collectively, may be helpful to investors because it provides consistency and comparability with past financial performance. However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool, and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP.

 

Investors are cautioned that there are material limitations associated with the use of non-GAAP financial measures as an analytical tool. Other companies, including companies in our industry, may calculate similarly titled non-GAAP measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of our non-GAAP financial measures as tools for comparison. We attempt compensate for these limitations by providing specific information regarding the GAAP items excluded from these non-GAAP financial measures.

 

Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures and not rely on any single financial measure to evaluate our business.

 

3

 

 

Adjusted EBITDA

 

We believe that Adjusted EBITDA, when considered with the financial statements determined in accordance with GAAP, is helpful to investors in understanding our performance and allows for comparison of our performance and credit strength to our peers. Adjusted EBITDA should not be considered alternatives to net loss as determined in accordance with GAAP as indicators of our performance or liquidity.

 

We define EBITDA as net loss before interest expense, provision for income taxes, depreciation and amortization. We calculate Adjusted EBITDA as EBITDA further adjusted to exclude the effects of the following items for the reasons set forth below:

 

Stock-based compensation expense, because this represents a non-cash charge and our mix of cash and share-based compensation may differ from other companies, which effects the comparability of results of operations and liquidity;

 

Cost incurred in connection with business combinations and mergers that are required to be expensed as incurred in accordance with GAAP, because business combination and merger related costs are specific to the complexity and size of the underlying transactions as well as the frequency of our acquisition activity these costs are not reflective of our ongoing operations;

 

Costs incurred in connection with non-recurring financing fees when we elect the fair value option to account for our debt instruments because if we had not elected the fair value option such costs would be recognized as an adjustment to the effective interest and excluded from EBITDA;

 

Restructuring charges because we believe these costs are not representative of operating performance;

 

Equity in earnings (losses) of investees because our share of the operations of investees is not representative of our own operating performance and may not be monetized for a number of years; and

 

Changes in fair value of contingent consideration because these adjustments are not recurrring across all periods and we believe these costs are not representative of operating performance.

 

Related Non-GAAP Expense Measure

 

We reference in our earnings call certain non-GAAP expense measures, including non-GAAP Operating Expenses, non-GAAP Product Development Expense, non-GAAP Sales and Marketing Expenses, and non-GAAP General and Administrative Expenses. We believe that these non-GAAP financial measures, when considered with the financial statements determined in accordance with GAAP, are helpful to management and investors in understanding our performance quarter over quarter and to the comparable quarter in our prior fiscal year by excluding the same items we exclude from EBITDA to derive Adjusted EBITDA, as set forth above (stock-based compensation expense, costs incurred with business combinations and mergers, costs incurred in connection with non-recurring financing fees, restructuring charges, equity in earnings (losses) of investees and changes in fair value of contingent consideration) for the same reasons stated above, principally, that these expenses are not, in management’s opinion, easily comparable across reporting periods, are not reflective of ongoing operations and/or are not representative of our operating performance.

 

4

 

 

We define non-GAAP Operating Expenses, non-GAAP Product Development Expense, non-GAAP Sales and Marketing Expenses and non-GAAP General and Administrative Expenses as, in each case, the corresponding GAAP financial measure (Operating Expenses, Product Development Expense, Sales and Marketing Expenses and General and Administrative Expenses) excluding that portion of depreciation and amortization, stock-based compensation expense, costs incurred with business combinations and mergers, costs incurred in connection with non-recurring financing fees, restructuring charges, equity in earnings (losses) of investees and changes in fair value of contingent consideration that is attributable to that specific GAAP financial measure.

 

This non-GAAP expense measure should not be considered an alternative to the corresponding GAAP financial measure as determined in accordance with GAAP as an indicator of our performance or liquidity. Please review the tables provided below, for a reconciliation of this non-GAAP expense measure to the corresponding GAAP financial measure.

 

The reconciliation of the above non-GAAP financial measures for the quarter ended June 30, 2021 are presented in the tables below. For comparative purposes, the reconciliation of these non-GAAP financial measures in the prior quarter ended March 31, 2021 are contained in our press release for that quarter dated May 10, 2021 and available on our website at www.akerna.com or in our current report on Form 8-K filed with the Securities and Exchange Commission on May 11, 2021 and available here:

https://www.sec.gov/Archives/edgar/data/0001755953/000121390021025543/ea140650ex99-1_akernacorp.htm

 

5

 

 

AKERNA CORP.

 Condensed Consolidated Balance Sheets

(unaudited)

 

   June 30,   December 31, 
   2021   2020 
Assets        
Current assets:        
Cash  $11,778,601   $17,840,640 
Restricted cash   508,261    500,000 
Accounts receivable, net   1,442,714    1,753,547 
Prepaid expenses and other current assets   2,395,346    2,458,727 
Total current assets   16,124,922    22,552,914 
           
Fixed assets, net   53,354    1,193,433 
Investment, net   226,101    233,664 
Capitalized software, net   5,213,267    3,925,739 
Intangible assets, net   7,772,289    7,388,795 
Goodwill   46,790,018    41,874,527 
Total Assets  $76,179,951   $77,169,072 
           
Liabilities and Equity          
           
Current liabilities          
Accounts payable, accrued expenses and other accrued liabilities  $4,681,554   $3,188,576 
Deferred revenue   825,187    843,900 
Current portion of long-term debt   7,155,953    11,707,363 
Derivative liability   354,247    311,376 
Total current liabilities   13,016,941    16,051,215 
           
Long-term debt, less current portion   1,200,647    3,895,237 
           
Total liabilities   14,217,588    19,946,452 
           
Commitments and contingencies          
           
Equity:          
Preferred stock, par value $0.0001; 5,000,000 shares authorized, 1 share special voting preferred stock issued and outstanding at June 30, 2021 and December 31, 2020        
Special voting preferred stock, par value $0.0001; 1 share authorized, issued and outstanding as of June 30, 2021 and December 31, 2020, with $1 preference in liquidation; exchangeable shares, no par value, 1,039,373 and 2,667,349 shares issued and outstanding as of June 30, 2021 and December 31, 2020 respectively   7,951,203    20,405,219 
Common stock, par value $0.0001; 75,000,000 shares authorized, 25,332,439 and 19,901,248 issued and outstanding at June 30, 2021 and December 31, 2020, respectively   2,533    1,990 
Additional paid-in capital   123,856,649    94,086,433 
Accumulated other comprehensive loss   (105,544)   (91,497)
Accumulated deficit   (69,742,478)   (57,179,525)
Total equity  $61,962,363   $57,222,620 
Total liabilities and equity  $76,179,951   $77,169,072 

 

6

 

 

AKERNA CORP.

 Condensed Consolidated Statements of Operations

(unaudited)

 

   For the Three Months Ended   For the Six Months Ended 
   June 30,   June 30, 
   2021   2020   2021   2020 
Revenues                
Software  $4,456,728   $2,849,734   $8,251,881   $5,196,043 
Consulting   410,884    131,000    583,631    823,584 
Other   39,275    22,904    85,399    54,557 
Total revenues   4,906,887    3,003,638    8,920,911    6,074,184 
Cost of revenues   1,914,380    1,818,565    3,368,547    3,214,784 
                     
Gross profit   2,992,507    1,185,073    5,552,364    2,859,400 
                     
Operating expenses                    
Product development   1,527,258    1,088,938    2,951,358    1,963,725 
Sales and marketing   1,826,143    2,117,118    3,562,058    4,157,869 
General and administrative   4,375,981    3,126,027    6,228,943    6,583,289 
Depreciation and amortization   1,314,132    1,036,378    2,367,015    1,216,607 
Total operating expenses   9,043,514    7,368,461    15,109,374    13,921,490 
                     
Loss from operations   (6,051,007)   (6,183,388)   (9,557,010)   (11,062,090)
                     
Other (expense) income:                    
Interest (expense) income , net   (163,125)   (2,084)   (937,504)   31,438 
Change in fair value of convertible notes   (16,405)   766,000    (2,007,667)   766,000 
Change in fair value of derivative liability   133,125    (606,958)   (42,871)   (370,041)
Other expense, net   243        243    (124)
Total other (expense) income   (46,162)   156,958    (2,987,799)   427,273 
                     
Net loss before income taxes and equity in losses of investee   (6,097,169)   (6,026,430)   (12,544,809)   (10,634,817)
Income tax expense   (4,300)   (30,985)   (10,570)   (30,985)
Equity in losses of investee   (3,782)   (3,692)   (7,564)   (3,692)
                     
Net loss   (6,105,251)   (6,061,107)   (12,562,943)   (10,669,494)
Net loss attributable to noncontrolling interest in consolidated subsidiary       748,584        849,759 
Net loss attributable to Akerna shareholders  $(6,105,251)  $(5,312,523)  $(12,562,943)  $(9,819,735)
                     
Basic and diluted weighted average common stock outstanding   24,530,837    13,166,444    22,879,131    12,871,648 
Basic and diluted net loss per common share  $(0.25)  $(0.46)  $(0.55)  $(0.83)

 

7

 

 

AKERNA CORP.

 Condensed Consolidated Statements of Cash Flows

(unaudited)

 

   For the Six Months Ended 
   June 30, 
   2021   2020 
Cash flows from operating activities        
Net loss  $(12,562,943)  $(10,669,494)
Adjustment to reconcile net loss to net cash used in operating activities:          
Equity in losses of investment   7,564    3,692 
Bad debt   150,294    370,154 
Stock-based compensation expense   1,074,621    760,584 
Loss on write off of fixed assets   1,045,180     
Amortization of deferred contract cost   242,110     
Non-cash interest expense   926,968     
Depreciation and amortization   2,367,014    1,216,607 
Debt issuance costs       1,177,390 
Foreign currency loss   (17,344)    
Change in fair value of convertible notes   2,007,677    (766,000)
Change in fair value of derivative liability   42,871    370,041 
Change in fair value of contingent consideration       (998,000)
Changes in operating assets and liabilities:          
Accounts receivable   641,111    (400,251)
Prepaid expenses and other current assets   (115,934)   (120,489)
Other assets        
Accounts payable and accrued liabilities   1,463,669    975,121 
Deferred revenue   (988,046)   (507,089)
Net cash used in operating activities   (3,715,198)   (8,587,734)
           
Cash flows from investing activities          
Developed software additions   (2,004,609)   (1,990,584)
Furniture, fixtures, and equipment additions       (156,636)
Cash paid for business combination, net of cash acquired       122,675 
Net cash used in investing activities   (2,004,609)   (2,024,545)
           
Cash flows from financing activities          
Value of shares withheld for related to tax withholdings   (333,847)    
Proceeds from issuance of long term debt       17,164,600 
Cash paid for debt issuance costs       (1,177,390)
Net cash (used in) provided by financing activities   (333,847)   15,987,210 
Effect of exchange rate changes on cash and restricted cash   (124)    
Net change in cash and restricted cash   (6,053,778)   5,375,207 
Cash and restricted cash - beginning of period   18,340,640    19,280,897 
Cash and restricted cash - end of period  $12,286,862   $24,655,829 
Cash paid for interest   50,854     
Cash paid for taxes   64,963    51,472 
Supplemental Disclosure of non-cash investing and financing activity:          
Settlement of convertible notes in common stock   10,196,382     
Conversion of exchangeable shares to common stock   12,453,853     
Settlement of other liabilities in common stock   377,325     

 

8

 

 

Akerna Corp.

Earnings Before Interest, Taxes, Depreciation and Amortization, and Adjusted EBITDA

The reconciliation of net loss to EBITDA and Adjusted EBITDA is as follows:

(unaudited)

 

   Three Months Ended June 30,   Six Months Ended June 30, 
   2021   2020   2021   2020 
Net loss  $(6,105,251)  $(6,061,107)  $(12,562,943)  $(10,669,494)
Adjustments:                    
Interest expense (income)   163,124    2,084    937,504    (31,438)
Change in fair value of convertible notes   16,405    (766,000)   2,007,677    (766,000)
Change in fair value of derivative  liability   (133,125)   606,958    42,871    370,041 
Income tax expense   4,300    30,985    10,570    30,985 
Depreciation and amortization   1,314,132    1,036,378    2,367,015    1,216,607 
EBITDA  $(4,740,415)  $(5,150,702)  $(7,197,306)  $(9,849,299)
Stock-based compensation expense   521,335    371,532    1,024,715    673,480 
Business combination and merger related  costs   63,735    1,026,929    107,726    2,245,361 
Non-recurring financing fees   111,761    1,177,390    129,594    1,177,390 
Restructuring charges   2,406,589        2,453,776     
Changes in fair value of contingent consideration       (998,000)       (998,000)
Equity in losses of investee   3,782    3,692    7,564    3,692 
Adjusted EBITDA  $(1,633,213)  $(3,569,159)  $(3,473,931)  $(6,747,376)

 

9

 

 

Akerna Corp.

The reconciliation of operating expenses to non-GAAP operating expenses is as follows:

(unaudited)

 

   Three Months Ended June 30,   Six Months Ended June 30, 
   2021   2020   2021   2020 
Operating Expenses  $9,043,514   $7,368,461   $15,109,374   $13,921,490 
Adjustments:                    
Depreciation and amortization   1,314,132    1,036,378    2,367,015    1,216,607 
Stock-based compensation expense   480,917    351,620    955,213    646,628 
Business combination and merger related costs   63,735    1,026,929    107,726    2,245,361 
Non-recurring financing fees   111,761    1,177,390    129,594    1,177,390 
Restructuring charges   2,406,589    -    2,453,776    - 
Changes in fair value of contingent consideration   -    (998,000)   -    (998,000)
Non-GAAP Operating Expenses  $4,666,380   $4,774,144   $9,096,050   $9,633,504 

 

10

 

 

Akerna Corp.

The reconciliation of product development expense to non-GAAP product development expense is as follows:

(unaudited)

 

   Three Months Ended June 30,   Six Months Ended June 30, 
   2021   2020   2021   2020 
Product development expense  $1,527,258   $1,088,938   $2,951,358   $1,963,725 
Stock-based compensation expense   186,013    93,520    407,907    109,295 
Non-GAAP product development expense  $1,341,245   $995,418   $2,543,452   $1,854,430 

 

11

 

 

Akerna Corp.

The reconciliation of sales and marketing expense to non-GAAP sales and marketing expenses is as follows:

(unaudited)

 

 

   Three Months Ended June 30,   Six Months Ended June 30, 
   2021   2020   2021   2020 
Sales and marketing expense  $1,826,143   $2,117,118   $3,562,058   $4,157,869 
Stock-based compensation expense   125,387    120,033    243,587    143,085 
Non-GAAP sales and marketing expense  $1,700,756   $1,997,085   $3,318,472   $4,014,784 

 

12

 

 

Akerna Corp.

The reconciliation of general and administrative expense to non-GAAP general and administrative expenses is as follows:

(unaudited)

 

   Three Months Ended June 30,   Six Months Ended June 30, 
   2021   2020   2021   2020 
General and administrative expense  $4,375,981   $3,126,027   $6,228,943   $6,583,289 
Adjustments:                    
Stock-based compensation expense   169,516    138,067    303,720    394,248 
Business combination and merger related costs   63,735    1,026,929    107,726    2,245,361 
Non-recurring financing fees   111,761    1,177,390    129,594    1,177,390 
Restructuring charges   2,406,589    -    2,453,776    - 
Changes in fair value of contingent consideration   -    (998,000)   -    (998,000)
Non-GAAP general and administrative expense  $1,624,379   $1,781,641   $3,234,127   $3,764,290 

 

 

13

 

View differences made from one to another to evaluate Akerna Corp.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Akerna Corp..

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator


Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not

Continue

Financial Stability Report


Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity

Continue

Get a Better Picture of a Company's Performance


Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years

Continue

Log in with your credentials

or    

Forgot your details?

Create Account